A Unique GPCR Company Redefining Therapeutics
Domain Therapeutics is a global clinical-stage biopharmaceutical company harnessing the untapped potential of GPCR science to develop breakthrough treatments and address unmet medical needs for patients, particularly in immuno-oncology and inflammation. With a unique and integrated approach to GPCR-targeting therapies, powered by a proven proprietary platform, a world-class team, and over two decades of expertise, we are redefining what is possible in drug discovery and development.
We are dedicated to developing breakthrough therapies that create 
meaningful change for patients with significant unmet needs
Our goal is to reshape the immune system, overcome treatment barriers, and deliver transformative clinical outcomes.
We envision a future where precision GPCR science drives
therapeutic advancements, outsmarting complex diseases
and transforming lives worldwide
Building on our expertise, innovative approach and proprietary platform, we are well-positioned to become
a fully integrated pharmaceutical company, delivering better treatments and creating lasting value for patients.
Driving value through innovative approaches and strategic partnerships
Founded on a bold vision to unlock GPCR biology, Domain has established itself as a trusted leader in GPCR science, developing a unique pipeline of first-in-class and best-in-class drug candidates with highly differentiated profiles. Over the last 20 years, our breakthrough developments have been powered by a proprietary drug discovery and development approach, global network of strategic partnerships with leading pharmaceutical companies, key opinion leaders (KOLs), and physicians, and the deep expertise of our experienced team, all focused on improving patient lives.
This collaborative spirit integrates internal innovation with external knowledge, fostering a dynamic environment for advancing life-changing therapies. By combining proprietary R&D, exploring novel modalities, and incorporating clinical insights into our drug development process, we are accelerating the transformation of groundbreaking science into impactful treatment solutions.
Visionary leadership and corporate culture
Our leadership team, comprised of visionaries and experts in the biopharmaceutical industry across North America and Europe, drives our strategic growth. Transparency, mutual respect, and open dialogue are at the heart of our success, fostering trust and enabling meaningful connections with patients, partners, and stakeholders. By encouraging respectful challenge and a commitment to innovation, we create an environment where diverse perspectives thrive.
Our progress is further supported by leading international venture capital firms. These partnerships, built on shared values and trust, drive sustainable growth and ensure the continued advancement of our GPCR-targeting therapeutics. Together, we are delivering better treatments for patients worldwide.
Scroll back top